WealthTrust-Arizona’s AstraZeneca AZN Stock Holding History

WealthTrust-Arizona’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$9K	Buy	123 +63	+105%	+$4.92K	0.01%	383
2018 Q3	$5K	Hold	60	–	–	﹤0.01%	500
2018 Q2	$4K	Hold	60	–	–	﹤0.01%	516
2018 Q1	$4K	Hold	60	–	–	﹤0.01%	505
2017 Q4	$4K	Hold	60	–	–	﹤0.01%	510
2017 Q3	$4K	Buy	60 +20	+50%	+$1.26K	﹤0.01%	510
2017 Q2	$3K	Hold	40	–	–	﹤0.01%	520
2017 Q1	$2K	Hold	40	–	–	﹤0.01%	538
2016 Q4	$2K	Hold	40	–	–	﹤0.01%	537
2016 Q3	$3K	Hold	40	–	–	﹤0.01%	516
2016 Q2	$2K	Buy	+40	New	+$2.32K	﹤0.01%	533

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

WealthTrust-Arizona's AZN Position: Q4 2018 in Review

WealthTrust-Arizona increased its AstraZeneca (AZN) stake by 105% in Q4 2018, buying an estimated $4.92K and bringing the position to 123 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #383.

WealthTrust-Arizona first reported a position in AZN in Q2 2016 and has held it in 11 quarters since. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

WealthTrust-Arizona held 123 shares of AstraZeneca worth $9K as of Q4 2018.
WealthTrust-Arizona bought 63 AstraZeneca shares in Q4 2018, an estimated $4.92K.
AstraZeneca made up 0.01% of WealthTrust-Arizona's portfolio in Q4 2018, its #383 holding.
WealthTrust-Arizona first reported a position in AstraZeneca in Q2 2016 and has held it in 11 quarters since.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.